Clinical Trial

Sarcopenia in Colorectal Cancer Patients, Intervention Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The sarcopenia is a new concept for evaluating the functional status of patients, introduced during the last 20 years. This is defined as the relationship between the deterioration of muscle mass and the decrease in strength, the metabolic rate, the aerobic capacity and subsequently the evaluation of the functional status. The sarcopenia has been estimated to affect 5% to 13% of people aged between 60 and 70 years, increasing from 11% to 50% in those aged 80 years and older. In a study by Lieffers et al. of a total of 234 patients with colorectal cancer, with a mean age of 63 years according to the values observed by Prado et al., the prevalence of sarcopenia would be around 39%, being able to reach up to 60% in patients with chronic diseases. The goal of this study is to compare the cumulative incidence of post-surgical complications due to infection at 30 days between the group of patients without sarcopenia and the group of patients with sarcopenia with an intervention based on a nutritional supplement + physical exercise.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-08-04; most recent amendment 2025-05-15.
Trial Details
NCT Number NCT05491434
Lead Sponsor Hospital Universitari de Bellvitge
Conditions Sarcopenia, Postoperative Complications, Infection;Post Surg Procedure
Enrollment 370 participants
Start Date 2020-12-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-20